[Event Report] Expert Meeting “The Future of Healthcare in Japan and Cost-Effectiveness Assessment” (December 14, 2018)
date : 12/17/2018
Tags: Future of the Health Care System, Innovation and Sustainability
HGPI and National Graduate Institute for Policy Studies (GRIPS) jointly convened the Expert Meeting “The Future of Healthcare in Japan and Cost-Effectiveness Assessment”.
Health Technology Assessment (HTA) is gaining prominence around the world as a means of appropriately assessing medical treatments. In Japan, since 2012 there have been many discussions held on the introduction of HTA, particularly at the Committee for Cost-Effectiveness Assessment within the Central Social Insurance Medical Council (Chuikyo). A trial introduction of Cost-Effectiveness Assessment was started in FY2016, and the issues and lessons that emerged through this trial introduction were reviewed in FY2017. In FY2018, the issues and lessons that emerged through the trial introduction have been discussed, while many other reviews have also been conducted with the aim of realizing the full-scale introduction of this unique endeavor by Japan to adjust the prices of pharmaceuticals and medical devices based on the results of Cost-Effectiveness Assessment.
Since 2016, the Health and Global Policy Institute (HGPI) has organized expert meetings and exchanges of opinions based on the theme “Rebalancing Healthcare Systems: Innovation and Sustainability.” In 2018, HGPI helped to deepen discussions by organizing five consecutive meetings.
At this meeting, leading experts from Japan and abroad discussed the issues identified so far and various stakeholders considered the respective roles that they should play, as well as the possible pathways toward resolving the issues.
*For past activities, please refer to the “Summary of Discussions in Past HGPI Meetings for the “Rebalancing Healthcare Systems: Innovation and Sustainability” Series (attached below).
■Overview
Opening (Explanation of the objectives of the meeting)
- Matt McEnany (Manager, Health and Global Policy Institute)
Opening Remarks
- Kiyoshi Kurokawa (Chairman, Health and Global Policy Institute)
Keynote Address 1 “Current Issues and the Future Outlook for the Sustainability of the Japanese Healthcare System”
- Hiroshi Nakamura (Professor, Graduate School of Business Administration, Keio University/ Public Member, Central Social Insurance Medical Council (Chuikyo)/ Chairperson, Chuikyo Special Committee on Drug Prices/ Acting Chairperson, Chuikyo Committee for Cost-Effectiveness Assessment)
Keynote Address 2 “Shifts to this Point and the Future Direction for Discussion Around Cost Effectiveness Assessments in Japan”
- Shigekazu Komoto (Counselor for Policy Planning, Coordination, Health Insurance Bureau, Ministry of Health, Labour and Welfare (MHLW))
Panel Discussion: “Issues and Future of Cost-Effectiveness Assessment – Toward a Unique Endeavor by Japan”
Panelists:
- Isao Kamae (Project Professor, Graduate School of Public Policy, The University of Tokyo)
- Hideo Kunitoh (Division of Chemotherapy, Department of Internal Medicine, Japanese Red Cross Medical Center)
- Shigekazu Komoto (Counselor for Policy Planning, Coordination, Health Insurance Bureau, Ministry of Health, Labour and Welfare (MHLW))
- Naomi Sakurai (President, Cancer Solutions Co., Ltd.)
- Chris Hourigan (Vice Chair, Pharmaceutical Research and Manufacturers of America (PhRMA))
Moderator:
- Joji Sugawara (Associate, Health and Global Policy Institute)
Closing Remarks
- Keizo Takemi (Member of the House of Councillors)
(No particular order, titles omitted)
(Photographed by: Kazunori Izawa)
Top Research & Recommendations Posts
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Final Version) (November 14, 2024)
- [Policy Recommendations] Integrating Climate and Health for a Sustainable Society: Incorporating a Planetary Health Perspective into Nationally Determined Contributions (NDCs)(December 9, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Policy Recommendations] The Women’s Health Promotion Project “Policy proposal for Promotion of Menopausal Women’s Health as a Social Issue to be Considered by Industry, Government, Academia and the Private Sector” (July 31, 2024)
- [Reserch Report] Antimicrobial Resistance (AMR) Measures in Sweden (November 21, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
Featured Posts
-
2024-11-25
[Registration Open] (Webinar) The 130th HGPI Seminar “Marking a Decade of the Act on Medical Care for Patients With Intractable Diseases: Connecting Intractable Diseases and Society From the Perspective of a Media Professional and Family Member” (January 28, 2025)
-
2024-11-29
[Registration Open] (Webinar) The 129th HGPI Seminar “The Connection Between Planetary Environment and Human Health as Seen Through the JECS and Future Expectations” (December 23, 2024)
-
2024-12-09
[Policy Recommendations] Integrating Climate and Health for a Sustainable Society: Incorporating a Planetary Health Perspective into Nationally Determined Contributions (NDCs)(December 9, 2024)
-
2024-12-12
[HGPI Policy Column] (No. 51) From the Planetary Health Project “Part 11: Efforts Toward Achieving Carbon Neutrality in Japan’s Pharmaceutical Industry”
-
2024-12-18
[Policy Recommendations] Policy Recommendations on Strengthening CKD Strategies for Workers: The Importance of Providing Early Detection, Intervention, and Support Through Screenings and Medical Visits (October 28, 2024)